Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry.

A cell counting method for MIB-1 immunohistochemistry, using an image analysis program, NIH Image, on a personal computer, has advantages over manual cell counting by microscopy. MIB-1 slides were photographed at a magnification of x 50 on 24 x 36 mm color films and the photographs were then enlarged to adequate size for observation. The MIB-1-positive cells, on the enlargements, were marked with a white pen, and negative cells with a black pen. Subsequently, the image of an enlargement was converted into data that can be processed by the program using a flatbed image scanner. Threshold levels were adjusted according to the respective white and black markings, and the program automatically counted the number of MIB-1-positive and negative tumor cells. Our method has the following significant advantages: Once cells had been marked and the image converted into the NIH Image data, the cell count process was completed within a few minutes; in contrast to manual microscopic cell counting, count overlapping or cells missed by the observer are eliminated; overlapping nuclei could be separated by the marking procedure; our method required no elaborate and costly image analysis system. The present method may be recommended to researchers undertaking cell kinetic studies utilizing immunohistochemical methods.

[1]  K. Takakura,et al.  Gamma knife radiosurgery for brain tumors: postirradiation volume changes compared with preradiosurgical growth fractions. , 1996, Neurologia medico-chirurgica.

[2]  C C Chang,et al.  Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. , 1988, Journal of neurosurgery.

[3]  M Bibbo,et al.  Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the microTICAS image analysis system. , 1987, Analytical and quantitative cytology and histology.

[4]  G. Pinkus,et al.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining. , 1989, The American journal of pathology.

[5]  M. Yamamoto,et al.  Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index. , 1995, Neurologia medico-chirurgica.

[6]  M. Prados,et al.  Prognostic implications of the bromodeoxyuridine labeling index of human gliomas. , 1989, Journal of neurosurgery.

[7]  H. Wakimoto,et al.  Prognostic significance of Ki‐67 labeling indices obtained using MIB‐1 monoclonal antibody in patients with supratentorial astrocytomas , 1996, Cancer.

[8]  D. Ellison,et al.  Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[9]  M. Jimbo,et al.  MIB‐1 staining index and peritumoral brain edema of meningiomas , 1996, Cancer.

[10]  T. Visakorpi,et al.  Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.

[11]  D. Benjamin,et al.  Proliferating cell nuclear antigen (PCNA) and pediatric tumors: assessment of proliferative activity. , 1991, Pediatric pathology.

[12]  J W Bacus,et al.  Biological grading of breast cancer using antibodies to proliferating cells and other markers. , 1989, The American journal of pathology.

[13]  M. Koike,et al.  Correlation between bromodeoxyuridine‐labeling indices and patient prognosis in cerebral astrocytic tumors of adults , 1991, Cancer.

[14]  M. Prados,et al.  Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling. , 1992, Neurosurgery.

[15]  F. Berger,et al.  Image analysis applied to proliferating cells in malignant lymphoma. , 1988, Cytometry.

[16]  D. Page,et al.  Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. , 1992, Human pathology.

[17]  C Lesty,et al.  Comparative quantitative study of Ki-67 antibody staining in 78 B and T cell malignant lymphoma (ML) using two image analyser systems. , 1992, Pathology, research and practice.